BSLN.SW SIX
Basilea Pharmaceutica AG
1W: -2.8%
1M: +1.8%
3M: +24.6%
YTD: +14.2%
1Y: +43.0%
3Y: +41.7%
5Y: +40.5%
CHF 66.80 ($80.63)
-1.00 (-1.47%)
Weekly Expected Move ±4.6%
CHF 61
CHF 64
CHF 67
CHF 70
CHF 73
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
📊 Key Metrics
TTMCHF 432M
Revenue
+33.6% YoY
CHF 117M
Net Income
+110.8% YoY
CHF 122M
Free Cash Flow
+233.0% YoY
87.0%
Gross Margin
26.5%
Op. Margin
23.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE130.7%
ROA48.1%
ROIC170.3%
Valuation
P/E15.7
P/B5.1
EV/EBITDA5.0
Leverage
Debt/Equity0.51
Current Ratio6.60
Interest Cov.18.7x
Quality Scores
Piotroski F8/9
Altman Z3.00
Beneish M-1.62